The clinical trial tech companies Medidata and Medable are both taking to the floor of the American Society of Clinical ...

The founder of 23andMe, Anne Wojcicki, has asked a federal bankruptcy court judge to reopen an auction for the genetic ...

Sanofi paid $55 million to partner with the biotech in 2019 and handed over a further $22 million to expand the collaboration ...

The first half of this year been riddled with market volatility and geopolitical tension. But 2025’s American Society of ...

Bristol Myers Squibb is paying BioNTech $3.5 billion to board the PD-1/L1xVEGF-A bandwagon. The deal, which features up to $7 ...

Regeneron isn’t the only Big Pharma to spot potential in Hansoh’s obesity pipeline. Merck & Co. ended last year paying $112 ...

In conversation with Fierce Biotech’s Chris Hayden, Austin Read, head of PPD™ CorEvitas™ Precision Medicine, Thermo Fisher ...

Be successful developing Internet of Healthcare Things with realtime medical device data integration. Learn more.

Discover how Bayer and BlueRock are redefining biotech partnerships. From breakthrough Parkinson’s therapies to a unique “arm ...

| When clinical trial steps are managed separately, the study suffers from compounded delays. Discover proven solutions from ...

Radiopharmaceuticals are transforming modern medicine, while simultaneously intensifying the pressures on pharmaceutical ...

Actuate Therapeutics has set its sights on getting elraglusib approved for pancreatic cancer after the glycogen synthase ...